Controversies and Challenges in the Management of Osteosarcoma-an Indian Perspective

Indian J Surg Oncol. 2022 Dec;13(4):939-955. doi: 10.1007/s13193-021-01486-3. Epub 2022 Jan 9.

Abstract

Osteosarcoma (OGS) is the most common primary bone tumor in children and adolescents which requires a multidisciplinary approach to management. Although chemotherapy and surgery can cure more than half of localized OGS cases, the unique challenges faced by resource-limited countries like India make this outcome difficult to achieve. Various questions in the management of OGS including role of high-dose methotrexate (HDMTX) in neoadjuvant setting, triplet vs doublet chemotherapy, intensification of chemotherapy based on response in setting of doublet, and indigenous prosthesis in setting of limb salvage need to be defined. Similarly, in the metastatic and recurrent setting, questions regarding intent of treatment, indications of chemotherapy, timing of surgery, and role of targeted therapies need clarification. Lack of randomized trials from India makes definite conclusions difficult, but an attempt can be made to define the best approach in the Indian scenario from available evidence. Hence, a critical review of literature from India and the West was done to define possible management approaches and highlight the lacuna for future research.

Keywords: Chemotherapy in osteosarcoma; High-dose methotrexate; Indian perspective; Limb salvage surgery; Relapsed osteosarcoma.

Publication types

  • Review